← All supplement guides
Worth it for some ⚠ Safety flag Food-grade · Evidence guide

Ashwagandha

Worth a short, cautious trial for stress and sleep — the evidence is decent — but a real (if rare) liver-injury signal means this is not the risk-free 'natural calm' it's marketed as.

Approved by a human reviewer Last reviewed Jul 6, 2026 5 primary sources

Before you take it

Education only, not medical advice. Standard consumer dosing is included because ashwagandha is a widely sold botanical supplement. Do NOT use it if you have liver disease, are pregnant or breastfeeding, or take medications affecting the liver, thyroid, or immune system — talk to a clinician first.

Full safety section ↓

The efficacy evidence for stress and sleep is actually reasonable for a botanical. What the marketing hides is a real, if uncommon, signal of ashwagandha-associated liver injury serious enough that a national regulator has issued an alert. Use it deliberately, short-term, and stop if anything feels off.

The one-paragraph version

Multiple meta-analyses find ashwagandha reduces perceived stress and anxiety and improves several sleep measures versus placebo, with the clearest effects at ~300–600 mg/day of standardized root extract for 8+ weeks S1S2S3. That's a genuinely better evidence base than most "calm" supplements have. But since 2017 there have been dozens of case reports of ashwagandha-associated liver injury, most mild-to-moderate and reversible but a few severe, and Australia's regulator flagged it in 2024 S4S5. This is not the consequence-free herbal the influencer market implies. A short, monitored trial is reasonable for healthy adults; long-term daily use and any use with liver risk factors is where caution turns into a hard stop.

What it is and how it works

Ashwagandha (Withania somnifera) is an adaptogenic botanical from Ayurvedic tradition. Its activity is attributed largely to withanolides, steroidal lactones; standardized extracts are dosed by withanolide content S1. Proposed mechanisms center on modulating the stress response, including lowering cortisol S1.

What the evidence actually supports

Stress and anxiety — decent for a botanical. A 2024 systematic review and meta-analysis found ashwagandha significantly reduced perceived stress and anxiety versus placebo, including a meaningful drop on the Perceived Stress Scale S2. NIH's fact sheet agrees the human evidence is suggestive of benefit while noting trials are short and varied in quality S1.

Sleep — modest, better in insomnia. A meta-analysis of sleep trials found benefits across sleep quality, onset latency, total sleep time, and efficiency, with more prominent effects in people diagnosed with insomnia, at doses ≥600 mg/day, and durations ≥8 weeks S3. A reasonable, evidence-backed option for stress-related poor sleep.

Testosterone and body composition — weaker, thinner. Small trials report increases in testosterone and training adaptations, but these rest on limited, often industry-linked studies and shouldn't be treated as established S1. Promising-but-unproven, not a reason to buy.

Who actually benefits

Healthy, stressed adults looking for a short-term aid for perceived stress or stress-related sleep are the best-supported use S1S2S3. It is not appropriate for people with liver disease or liver risk factors, pregnancy/breastfeeding, thyroid disorders (it can affect thyroid hormones), or those on immunosuppressants or hepatotoxic drugs S1S4.

Dosing (standard, well-established)

Trials most commonly use 300–600 mg/day of a standardized root extract, often split into two doses, for 8–12 weeks S1S2S3. Longer-term daily use is not well studied — a time-limited trial with breaks is the more defensible pattern given the liver-safety uncertainty. Standardization to withanolide content matters more than raw milligrams.

Safety

Short-term use in trials is generally well tolerated, with mild GI upset and drowsiness the usual complaints S1. The real concern is the liver: LiverTox classifies ashwagandha as a cause of clinically apparent liver injury, and case series and reports — dozens since 2017, with Australia's TGA issuing a 2024 safety alert after multiple reports including hospitalizations — describe injury that is usually reversible on stopping but occasionally severe S4S5. The true incidence is unknown because the denominator (how many users) isn't. Practical rules: don't stack it with alcohol or other hepatotoxic supplements, avoid it entirely with existing liver disease, and stop and seek care for jaundice, dark urine, right-upper-abdominal pain, or unusual fatigue.

The marketing myths

  • "Natural, so it's safe." The clearest myth here — a documented liver-injury signal says otherwise S4S5.
  • "Take it every day indefinitely for calm." Long-term safety isn't established; short, monitored courses are the defensible pattern S1.
  • "It'll raise your testosterone and build muscle." The evidence is small and often industry-linked — not established S1.
  • "All ashwagandha is equivalent." Effects track standardized withanolide content and extract type, not just the milligram number on the front.

Sources

Every reference below is a primary source cited in this guide.

Follow this guide

Get an email if a major trial or safety alert changes this verdict.

Follow this

The Panel Brief

What moved in supplement & peptide regulation this week. Free, cited, unsubscribe anytime.

You must be 18 or older to create an account.